BioCentury
ARTICLE | Company News

Arc Pharma, McGill University deal

August 19, 2002 7:00 AM UTC

The parties will develop antisense therapeutics to treat cancer. The deal combines Arc's polymeric drug delivery technology with the university's antisense technology. Arc has an option to exclusively...